Five tips: Assessing and managing drug-related problems in cognitive impairment and dementiaFive pearls you can use in your practice now. Changing packaging regulations could reduce acetaminophen overdoses: ISMP CanadaThere are 4,500 hospitalizations from acetaminophen overdoses in Canada each year. Antibiotics and acid suppressants may be behind increased pediatric eosinophilic esophagitis Danish study found a 40% to 80% increased risk. Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them. Publicly funded genetic test for suitable antidepressants would save healthcare costs: study Genes are responsible for about 42% of the variation in how people respond to antidepressants. Older Canadians take more prescription opioids than any other age group: report Older adults also more vulnerable to overdosing, hospitalization and death from them. Tool helps pharmacists and physicians see interactions between cannabinoids and other medications The free CANNabinoid Drug Interaction Review allows pharmacists and other healthcare professionals to quickly see if there is a potential interaction. Polypharmacy rising among seniors with heart failure Quebecers aged 65 and over with heart failure are taking more and more different pharmacological treatments, according to a new study What happens when drugs don’t have to be tested on people who are obese More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies. U.S. FDA approves new version of diabetes drug Mounjaro for weight loss Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. First Previous 48 49 50 51 52 Next Last
